Insufficient scRNA-seq data for expression of TAL2 at single-cell level.
Insufficient scRNA-seq data for expression of TAL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 97% | 12.40 | 86 / 89 | 65% | 5.36 | 589 / 901 |
brain | 86% | 6.29 | 2277 / 2642 | 25% | 0.40 | 173 / 705 |
liver | 76% | 3.58 | 171 / 226 | 22% | 0.63 | 89 / 406 |
adrenal gland | 85% | 5.76 | 219 / 258 | 12% | 0.57 | 28 / 230 |
muscle | 92% | 47.73 | 740 / 803 | 0% | 0 | 0 / 0 |
breast | 71% | 3.52 | 327 / 459 | 20% | 0.69 | 223 / 1118 |
spleen | 90% | 6.74 | 217 / 241 | 0% | 0 | 0 / 0 |
uterus | 75% | 4.49 | 128 / 170 | 11% | 0.29 | 49 / 459 |
intestine | 78% | 4.23 | 754 / 966 | 6% | 0.10 | 31 / 527 |
prostate | 75% | 4.52 | 183 / 245 | 7% | 0.18 | 35 / 502 |
thymus | 79% | 4.36 | 518 / 653 | 1% | 0.03 | 6 / 605 |
ovary | 78% | 4.82 | 140 / 180 | 2% | 0.04 | 8 / 430 |
stomach | 69% | 3.04 | 246 / 359 | 7% | 0.13 | 21 / 286 |
esophagus | 64% | 2.84 | 932 / 1445 | 8% | 0.16 | 15 / 183 |
heart | 71% | 3.53 | 612 / 861 | 0% | 0 | 0 / 0 |
adipose | 71% | 3.33 | 851 / 1204 | 0% | 0 | 0 / 0 |
skin | 67% | 3.54 | 1214 / 1809 | 3% | 0.04 | 13 / 472 |
lung | 62% | 3.09 | 361 / 578 | 6% | 0.14 | 67 / 1155 |
pancreas | 60% | 2.39 | 196 / 328 | 3% | 0.15 | 5 / 178 |
blood vessel | 62% | 2.83 | 823 / 1335 | 0% | 0 | 0 / 0 |
bladder | 52% | 2.05 | 11 / 21 | 4% | 0.09 | 19 / 504 |
peripheral blood | 34% | 2.99 | 315 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 20% | 0.86 | 9 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021794 | Biological process | thalamus development |
GO_0035264 | Biological process | multicellular organism growth |
GO_0009791 | Biological process | post-embryonic development |
GO_0030901 | Biological process | midbrain development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | TAL2 |
Protein name | T-cell acute lymphocytic leukemia protein 2 (TAL-2) (Class A basic helix-loop-helix protein 19) (bHLHa19) |
Synonyms | BHLHA19 |
Description | |
Accessions | ENST00000334077.6 Q16559 |